web analytics
August 2, 2015 / 17 Av, 5775
At a Glance
News & Views
Sponsored Post


Teva’s Parkinson Drug Now Marketed in Japan

Japan’s largest pharmaceutical company, Takeda, recently signed an agreement with Teva Pharmaceutical Industries to commercialize the Israeli company’s innovative treatment for Parkinson’s disease, rasagiline, in Japan.

The rasagiline tablets, which are approved in over 40 countries for the treatment of Parkinson’s disease, gained UK and EU-marketing authorization in 2005 and US FDA approval in 2006.

“It is estimated there are about 150,000-180,000 people diagnosed with Parkinson’s disease in Japan, many of whom are waiting for a new treatment option,” said Nancy Joseph-Ridge, M.D., General Manager of Takeda’s Pharmaceutical Development Division located in Osaka, Japan in a press release on April 27.

“We will continue working on the development in cooperation with Teva so that we can bring this medicine to Japanese patients as quickly as possible,” Joseph-Ridge said.

“This agreement represents Teva’s continued commitment to introducing our innovative medicines to patients in Japan,” added Teva Global R&D president and Chief Scientific Officer, Dr. Michael Hayden.

Teva and Takeda entered an agreement in December 2013 to develop glatiramer acetate for the treatment of multiple sclerosis.

Developed by Teva, rasagiline was initially discovered by two Haifa Technion professors, John Finberg and Moussa Youdim, who were instrumental in the early clinical development of the anti-Parkinson drug.

Parkinson’s disease is a degenerative disorder of the central nervous system, whose symptoms include shaking, rigidity, slowness of movement and difficultly with walking as well as dementia in advanced stages. An estimated seven to 10 million people suffer from the disease across the world according to the Parkinson’s Disease Foundation.

According to Teva’s website, rasagiline is a monoaxmine oxidase B (MAO-B) inhibitor that increases available synaptic dopamine in the brain, which might improve the motor symptoms characteristic of Parkinson’s, slowing the progression of the disease.

“Rasagiline has an established safety and efficacy profile…[it] will be an important product for Japan, where the number of available treatment options for Parkinson’s disease remains limited,” said Dr. Hayden.

About the Author: Anav Silverman is a regular contributor to Tazpit News Agency.


If you don't see your comment after publishing it, refresh the page.

Our comments section is intended for meaningful responses and debates in a civilized manner. We ask that you respect the fact that we are a religious Jewish website and avoid inappropriate language at all cost.

If you promote any foreign religions, gods or messiahs, lies about Israel, anti-Semitism, or advocate violence (except against terrorists), your permission to comment may be revoked.

2 Responses to “Teva’s Parkinson Drug Now Marketed in Japan”

  1. Judith Dowla says:

    TEVA is an excellent pharmaceutical company that offers a considerable amount of funds into research and is on the leading edge in finding the best possible treatment for various diseases and with a focus as well on receptors involving the nerves that become disturbed via a variety of causes. The goal is to do what is best to help the patient overcome and manage the disturbances that can make life very uncomfortable. Keep up the good work TEVA.

Comments are closed.

Current Top Story
Thousands of Israelis at an anti-violence and anti-homophobia rally in Tel Aviv Saturday night.
Rally against Violence Bars Religious MKs and Boos Right-Winger
Latest News Stories

Drivers of the Jerusalem Light Rail system shut down the trains in a wildcat strike Sunday morning leaving tens of thousands people stranded. The drivers are protesting work conditions and the increased frequency of trains. The Transportation Ministry is deploying hundreds of additional buses to try to overcome the sadden lack of train service. CityPass, […]

Thousands of Israelis at an anti-violence and anti-homophobia rally in Tel Aviv Saturday night.

Homosexual leaders who organized last night’s rally in Tel Aviv demanded that speakers sign a pledge supporting their cause.

Former liberal Democratic New York Congressman Gar Ackerman has come out four-square against the nuclear deal with Iran, Ackerman, who was New York City’s 7th District Congressman for 30 years until 2013 and is 72 years old, has joined the advisory board of Citizens for a Nuclear Free Iran. He stated Friday: While I have […]

sharks2

The surfer got back to shore and saw there had been two sharks circling him.

Cong. Albio Sires of New Jersey is the third Democrat so far to come out against the JCPOA because it won’t bar Iran from becoming a nuclear state

No one envied the Iranian last week, with temperatures above 150 Farenheit. In Israel, it hit above 100 degrees.

Sandy Berger: “Going forward, if Bibi continues to be the obstacle, you will need to find the ground from which you can make his politics uneasy.”

The plaintiff allege that a building manager told them to “Go somewhere else if you don’t like it.”

Gaza terrorists launched a double rocket attack late Saturday, but Israelis weren’t warned. The rockets miraculously landed short.

Here is a long, but incomplete, list of Arab attacks over Shabbat…

Palestinian Authority Arabs attempt to torch Joseph’s tomb in retaliation for Duma arson attack.

Israel Police are on nationwide ‘high alert’ in response to an uptick in Arab violence.’

Arabs attacked Israeli forces in Jerusalem, Judea and Samaria on Sabbath over the deaths of an innocent baby and a terrorist.

There were no injuries, but the bus was badly damaged.

State Dept. claims Congress is “looped in,” but IAEA head refuse to testify at Senate hearings.

They are throwing rocks and blocks at the drivers as they drive by.

More Articles from Anav Silverman, Tazpit News Agency
Orna and Hodaya Giat originally from Kfar Darom stand near photos of their Gush Katif community at a photography exhibition at an event marking 10 years to the Disengagement at the President's Residence in Jerusalem July 2015

“I still wait to return,” Hodaya Giat said, “I still have hope that someday we can return to the beaches, to our homes.”

ome of the 95 children who made Aliyah on today’s Nefesh B’Nefesh charter flight facilitated in cooperation with Israel’s Ministry of Aliyah & Immigrant Absorption, The Jewish Agency for Israel, Keren Kayemeth Le’Israel, and JNF-USA. July 14, 2015.

On board were 32 families including 95 children and 53 singles, of whom 12 will be joining the Israel Defense Forces.

The Temple Institute is working together with an Israeli cattleman to raise a red heifer in Israel.

The Israeli wetlands are among the 2,208 Ramsar wetland sites from across 169 countries around the world.

“The idea of adapting the unit actually came from our soldiers who recognized the need for it in the field,” explained Captain Dr. Lev.

The House of Bishops, led by Presiding Bishop Katharine Jefferts Schori, overwhelmingly defeated the Boycott, Divestment, Sanctions resolution.

Mirella Petteni Haggiag, a former Italian model from Rome, makes her way through the tombstones with a garbage bag in her hand several times of year when she visits Israel.

Reminiscent of ISIS, Arabs continue to destroy Jewish graves on the Mount of Olives.

Printed from: http://www.jewishpress.com/news/breaking-news/tevas-parkinson-drug-now-marketed-in-japan/2014/05/29/

Scan this QR code to visit this page online: